These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12743642)

  • 1. Telomerase as a promising target for human cancer gene therapy.
    Saretzki G; von Zglinicki T
    Drugs Today (Barc); 2003 Apr; 39(4):265-76. PubMed ID: 12743642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase inhibition as cancer therapy.
    Saretzki G
    Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomeres and telomerase as targets for cancer therapy.
    Zimmermann S; Martens UM
    Cell Mol Life Sci; 2007 Apr; 64(7-8):906-21. PubMed ID: 17310277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer.
    Sekhri K
    J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase inhibitors as anticancer therapy.
    Akiyama M; Hideshima T; Munshi NC; Anderson KC
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing telomerase in cancer therapeutics.
    Fakhoury J; Nimmo GA; Autexier C
    Anticancer Agents Med Chem; 2007 Jul; 7(4):475-83. PubMed ID: 17630922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiopathologic implications of telomerase].
    Santos Ruiz A; Cascales Angosto M
    An R Acad Nac Med (Madr); 2000; 117(2):427-44; discussion 444-7. PubMed ID: 11209552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere and telomerase as targets for anti-cancer and regeneration therapies.
    Hsu YH; Lin JJ
    Acta Pharmacol Sin; 2005 May; 26(5):513-8. PubMed ID: 15842766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anticancer therapeutics targeting telomerase.
    Ruden M; Puri N
    Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
    Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
    Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase: a target for cancer therapeutics.
    Shay JW; Wright WE
    Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
    Philippi C; Loretz B; Schaefer UF; Lehr CM
    J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapies.
    Folini M; Zaffaroni N
    Curr Pharm Des; 2005; 11(9):1105-17. PubMed ID: 15853659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of telomerase activation and cellular immortalization in human cancer.
    Newbold RF
    Mutagenesis; 2002 Nov; 17(6):539-50. PubMed ID: 12435851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
    Shammas MA; Koley H; Beer DG; Li C; Goyal RK; Munshi NC
    Gastroenterology; 2004 May; 126(5):1337-46. PubMed ID: 15131795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.